Oncotarget New Tool Uses NF-κB Activity to Classify HPV+ Head and Neck Cancer Researchers developed a new tool aimed at better classifying HPV+ HNSCC patients with good or... read more May 26, 2022
Oncotarget Trending with Impact: Antibody Drug Improves Non-HPV Oropharynx Cancer Researchers perform a phase three subgroup analysis study demonstrating positive results in patients with HPV-negative... read more January 7, 2021